First published: 20 July 2020

Outcomes of COVID-19 in Patients with CLL: A Multicenter, International Experience

Clinical Trials & Observations

Anthony R. Mato, Lindsey Elizabeth Roeker, Nicole Lamanna, John Allan, Lori Ann Leslie, John M. Pagel, Krish Patel, Anders Osterborg, Daniel Wojenski, Manali Kamdar, Scott F Huntington, Matthew S. Davids, Jennifer R. Brown, Darko Antic, Ryan W Jacobs, Inhye E Ahn, Jeffrey J Pu, Krista Isaac, Paul M. Barr, Chaitra Ujjani, Mark Blaine Geyer, Ellin Berman, Andrew D. Zelenetz, Nikita Malakhov, Richard R. Furman, Michael Koropsak, Neil Bailey, Lotta Hansson, Guilherme Fleury Perini, Shuo Ma, Christine E. Ryan, Adrian Wiestner, Craig A Portell, Mazyar Shadman, Elise A. Chong, Danielle M. Brander, Suchitra Sundaram, Amanda N. Seddon, Erlene Seymour, Meera Patel, Nicolas Martinez-Calle, Talha Munir, Renata Walewska, Angus Broom, Harriet Sarah Walter, Dima El-Sharkawi, Helen Parry, Matthew R. Wilson, Piers E Patten, José-Ángel Hernández-Rivas, Fatima Miras, Noemi Fernández Escalada, Paola Ghione, Chadi Nabhan, Sonia Lebowitz, Erica B Bhavsar, Javier López-Jiménez, Daniel Naya, Jose Antonio Garcia-Marco, Sigrid S Skånland, Raul Cordoba, Toby Andrew Eyre

KEY POINTS:

• Both watch and wait and treated CLL patients when admitted for COVID-19 have high mortality rates.
• Receiving a BTKi for CLL at COVID-19 diagnosis severe enough to require hospitalization did not influence case fatality rate in this study

This ASH paper is the largest multicentre study to date in CLL!

Please access the full article here.

First published: 9 July 2020

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

Lydia Scarfò,^#1 Thomas Chatzikonstantinou,^#2 Gian Matteo Rigolin,^#3 Giulia Quaresmini,⁴ Marina Motta,⁵ Candida Vitale,⁶ Jose Antonio Garcia-Marco,⁷ José Ángel Hernández-Rivas,⁸ Fatima Mirás,⁹ Mónica Baile,¹⁰ Juan Marquet,¹¹ Carsten U. Niemann,¹² Gianluigi Reda,¹³ Talha Munir,¹⁴ Eva Gimeno,¹⁵ Monia Marchetti,¹⁶ Francesca Maria Quaglia,¹⁷ Marzia Varettoni,¹⁸ Julio Delgado,¹⁹ Sunil Iyengar,²⁰ Ann Janssens,²¹ Roberto Marasca,²² Angela Ferrari,²³ Carolina Cuéllar-García,²⁴ Gilad Itchaki,²⁵ Martin Špaček,²⁶ Lorenzo De Paoli,²⁷ Luca Laurenti,²⁸ Mark-David Levin,²⁹ Enrico Lista,³⁰ Francesca R. Mauro,³¹ Martin Šimkovič,³² Ellen Van Der Spek,³³ Elisabeth Vandenberghe,³⁴ Livio Trentin,³⁵ Ewa Wasik-Szczepanek,³⁶ Rosa Ruchlemer,³⁷ Dominique Bron,³⁸ Maria Rosaria De Paolis,³⁹ Giovanni Del Poeta,⁴⁰ Lucia Farina,⁴¹ Myriam Foglietta,⁴² Massimo Gentile,⁴³ Yair Herishanu,⁴⁴ Tobias Herold,⁴⁵ Ozren Jaksic,⁴⁶ Arnon P. Kater,⁴⁷ Sabina Kersting,⁴⁸ Lara Malerba,⁴⁹ Lorella Orsucci,⁵⁰ Viola Maria Popov,⁵¹ Paolo Sportoletti,⁵² Mohamed Yassin,⁵³ Barbara Pocali,⁵⁴ Gabor Barna,⁵⁵ Annalisa Chiarenza,⁵⁶ Gimena dos Santos,⁵⁷ Eugene Nikitin,⁵⁸ Martin Andres,⁵⁹ Maria Dimou,⁶⁰ Michael Doubek,⁶¹ Alicia Enrico,⁶² Yervand Hakobyan,⁶³ Olga Kalashnikova,⁶⁴ Macarena Ortiz Pareja,⁶⁵ Maria Papaioannou,⁶⁶ Davide Rossi,^67,68 Nimish Shah,⁶⁹ Amit Shrestha,⁷⁰ Oana Stanca,⁷¹ Niki Stavroyianni,² Vladimir Strugov,⁷² Constantine Tam,⁷³ Mihnea Zdrenghea,⁷⁴ Marta Coscia,⁶ Kostas Stamatopoulos,⁷⁵ Giuseppe Rossi,⁵ Alessandro Rambaldi,⁴ Emili’ Montserrat,¹⁹ Robin Foà,³¹ Antonio Cuneo,³ and Paolo Ghia¹

Published in Blood: 17 April 2020

The BTK-inhibitor ibrutinib may protect against pulmonary injury in COVID-19 infected patients

Steven P Treon, Jorge Castillo, Alan P Skarbnik, Jacob D Soumerai, Irene M Ghobrial, Maria Luisa Guerrera, Kirsten E. Meid, Guang Yang

Paper from latest ASH COVID related publications.

Please access the full article here

First published: 7 May 2020

Survival study of hospitalized patients with concurrent Covid‐19 and haematological malignancies

Fernando Martín‐Moro, Juan Marquet, Miguel Piris, Berta M Michael, Adolfo J Sáez, Magdalena Corona, Carlos Jiménez, Beatriz Astibia, Irene García, Eulalia Rodríguez, Carlota García‐Hoz, Jesús Fortún‐Abete, Pilar Herrera, Javier López‐Jiménez

This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.1111/bjh.16801

Please access the full article here

First published: 30 April 2020

Management of CLL Patients Early in the COVID‐19 Pandemic: An International Survey of CLL Experts

Brian Koffman, Anthony Mato, John C. Byrd, Alexey Danilov, Brad Hedrick, Chaitra Ujjani, Lindsey Roeker, Deborah M. Stephens, Matthew S. Davids, John M. Pagel, Mazyar Shadman

You can access the full article here.

This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/ajh.25851.

Published: 30 April 2020

Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia

S. Paneesha,^a,b G. Pratt,^a,b H. Parry,^a,b and P. Moss^a,b,⁎

You can access the full article here.

Published: 24 April 2020

COVID-19 in persons with haematological cancers

• Wenjuan He, Lei Chen, Li Chen, Guolin Yuan, Yun Fang, Wenlan Chen, Di Wu, Bo Liang, Xiaoting Lu, Yanling Ma, Lei Li, Hongxiang Wang, Zhichao Chen, Qiubai Li & Robert Peter Gale

You can access the full article here.